title: Conversion from regular cyclosporine to microemulsion cyclosporine following heart transplantation.
authors.affiliation: Heart Failure, Heart Transplantation Program, Quebec City Heart Institute, Hôpital Laval, Canada.
authors.forename: A L
authors.initials: AL
authors.lastname: Heroux
authors.forename: M H
authors.initials: MH
authors.lastname: LeBlanc
authors.forename: D
authors.initials: D
authors.lastname: Beaudoin
authors.forename: S
authors.initials: S
authors.lastname: Simard
authors.forename: D A
authors.initials: DA
authors.lastname: Coulombe
authors.forename: O
authors.initials: O
authors.lastname: Gleeton
authors.forename: M D
authors.initials: MD
authors.lastname: Lemieux
authors.forename: D P
authors.initials: DP
authors.lastname: Doyle
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use; D001707:Biopsy, Needle; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004655:Emulsions; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone